for December 2018
3 reasons for EFFECTIVE immigration control:
— David A. Clarke, Jr. (@SheriffClarke) December 1, 2018
1) Domestic and national security
2) PREVENT THE SPREAD OF INFECTIOUS DISEASES
3) Control the influx of another country’s ne’er-do-wells
All 3 conditions are present in this INVASION at our southern border.https://t.co/BnTSqVip52
Let me say this again.
— David A. Clarke, Jr. (@SheriffClarke) December 1, 2018
3 reasons for EFFECTIVE immigration control:
1) DOMESTIC AND NATIONAL SECURITY
2) Prevent the spread of infectious diseases
3) Control the influx of another country’s ne’er-do-wellshttps://t.co/dT50xkvJBM
NEW by Dr. Mical Paul🔥🔥in CID
— Antibiotic Steward (@ABsteward) December 11, 2018
Seven versus fourteen Days of Antibiotic Therapy for uncomplicated Gram-negative Bacteremia: a Non-inferiority Randomized Controlled Trial. Shorter is better.
Could be the Best study of 2018https://t.co/R5G0HrZIn8 pic.twitter.com/beiwhXWDLh
A new cohort study in @PharmacoJournal :
— Antibiotic Steward (@ABsteward) December 3, 2018
Among critically ill patients who receive antipseudomonal β‐lactam antibiotics, each additional day of exposure to cef, mero, and pip tazo is associated with an increased risk of new resistance development. https://t.co/ERhrGgbp12 pic.twitter.com/FOYhLTHMVi
JUST released 🔥🔥
— Antibiotic Steward (@ABsteward) December 11, 2018
Our monthly top NEW articles in the fields of antimicrobial stewardship & infectious Diseases. Great collaboration with @IDstewardshiphttps://t.co/ArhdKNKZj6 pic.twitter.com/GaCRQSJS22
Carbapenem versus Cefepime or Piperacillin-Tazobactam for the Empiric Treatment of Extended Spectrum β-lactamase Producing Escherichia coli Bacteremia in Patients with Hematologic Malignancy. A NEW retrospective cohort study @OncIDPharmd@ASMicrobiologyhttps://t.co/er2dPp2tTe pic.twitter.com/klp3jcTMtd
— Antibiotic Steward (@ABsteward) December 3, 2018
NEW 🔥🔥 review article in @PharmacoJournal by @Crasspofungin / @DosingMatters
— Antibiotic Steward (@ABsteward) December 27, 2018
Pharmacokinetics and Pharmacodynamics of Beta‐lactamase Inhibitors. Great work 👏https://t.co/UluqdiQrOE pic.twitter.com/DGanRPLbED
Antibiotic Allergy @TheLancet - A comprehensive review article of mechanisms, cross-reactivity and #delabelling! @id_austin @Austin_Health @CAAR_Aus @NCICancer @VUMChealth @KimberlyBlumen1 https://t.co/5EtFq4ztA0
— Jason Trubiano (@TrubianoJason) December 15, 2018
NEW🔥 large retrospective cohort study in OFID
— Antibiotic Steward (@ABsteward) December 13, 2018
No Impact of Probiotics to Reduce Clostridium difficile Infection in Hospitalized Patients. https://t.co/E2K44WaTpQ pic.twitter.com/2ZpPwwiraY
The NIH study uses legally donated human fetal tissue to modify the immune systems of lab mice, making them comparable to human systems.
— Matthew Wolff 🏳️🌈 (@MatthewWolfff) December 11, 2018
The ban halts the HIV study as well as studies into other infectious diseases, as well as on human eye diseases.https://t.co/OaIWcuINPg
Breaking news. @IDSAInfo
— Antibiotic Steward (@ABsteward) December 19, 2018
NEW🔥🔥 Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza. https://t.co/CZjJedT8uX pic.twitter.com/YSUboZqzYN
New IDSA Guidelines for Influenza - just in time. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza a https://t.co/QTenjdIyyl
— Andrew Pavia (@AndrewPaviaMD) December 19, 2018
NEW 🔥Review Article in the annals of Pharmacotherapy by @HanaRac @miaPharmD @BBookstaver_USC @blandman19 @stoverkr
— Antibiotic Steward (@ABsteward) December 17, 2018
The treatment of common bacterial and viral infections occurring in the pregnant patient. https://t.co/l6r8I4Gld9 pic.twitter.com/99GkUukpIc
NEW🔥 in @ASMicrobiology by Dr. Vincent Tam @SIDPharm
— Antibiotic Steward (@ABsteward) December 10, 2018
Optimal Piperacillin/Tazobactam Dosing Strategies against ESBL-producing Enterobacteriaceaehttps://t.co/vmaaeoqRs5 pic.twitter.com/pGNcc2li54
NEW🔥 Multicenter Quasi-experimental study in CID by Dr. Cosgrove /Tamma/ Avdic Prescriber driven time-outs without input from antibiotic stewardship teams are insufficient to optimize antibiotics prescribing in hospitalized patients. https://t.co/LuZKJePJq2 pic.twitter.com/NVpO5BYy3L
— Antibiotic Steward (@ABsteward) December 4, 2018
A NEW🔥🔥RCT just published in OFID:A 2-dose regimen of weekly Dalbavancin is effective and well-tolerated for the treatment of osteomyelitis in adults. #opat https://t.co/knpklzfR2D pic.twitter.com/vLfJ0S0Ze7
— Antibiotic Steward (@ABsteward) December 8, 2018
ALARMING: "...herbicides used on a mass industrial scale in agriculture, but not intended to be antibiotics, can have profound effects on bacteria, with potentially negative implications for medicine’s ability to treat infectious diseases..." https://t.co/GqKAVICaAz via @GMWatch
— Timothy A. Wise (@TimothyAWise) December 13, 2018
Study discovers > 6,000 antibiotic resistance genes in gut #microbiota .
— Microbes&Infection (@MicrobesInfect) December 1, 2018
Scientists identified resistance genes in gut bacteria by comparing the 3D structures of known #AntibioticResistance enzymes to the proteins that are produced by gut bacteria.https://t.co/4c1I8yGC8Z pic.twitter.com/bmgPqil6Ub
Impact of de-escalation on prognosis of patients with bacteraemia due to Enterobacteriaceae: a post-hoc analysis from a multicenter prospective cohort. NEW In CID BY @jesusrbano. 🇪🇸https://t.co/BJdxsq5YVq pic.twitter.com/kqRGiZfFT3
— Antibiotic Steward (@ABsteward) December 8, 2018
KEY READ! The Impact of Social Media on Antimicrobial Stewardship Programs: Background on the Management of Drug-Resistant Bacterial Infections https://t.co/StnsmFjaC7 @JohnNosta @idpharmd #infection #socialmedia #medicine
— JOHN NOSTA (@JohnNosta) December 14, 2018
NEW 🔥in OFID by @BradSpellberg Expected Practice as a Novel Antibiotic Stewardship Intervention https://t.co/LX2BMYxbKt pic.twitter.com/JxzBtkFURI
— Antibiotic Steward (@ABsteward) December 3, 2018
Day #6 On-Service ID Learning Unit: Linezolid vs vancomycin in MRSA pneumonia. Controversial clinical trial at the time--but critiques notwithstanding, linezolid at least as good as (and possibly better than) vanco for Staph aureus pneumonia.https://t.co/Lpr2Dzw950
— Paul Sax (@PaulSaxMD) December 2, 2018
A NEW review article in @PharmacoJournal
— Antibiotic Steward (@ABsteward) December 3, 2018
Prevention of Clostridium difficile Infection in Critically Ill Adults. https://t.co/i7AOJmrAQ7 pic.twitter.com/1gR6nRvErv
NEW🔥 Multicenter study in OFID JUST Published by Dr. Tamma/Cosgrove / Avdic :Role of Ertapenem for the Treatment of Complicated Intra-abdominal Infections with a Positive Culture for Enterococcus faecalis. https://t.co/OIQjVBGoVC pic.twitter.com/q5l58875xp
— Antibiotic Steward (@ABsteward) December 15, 2018
All aboard!: Involvement of medical and pharmacy trainees in antimicrobial stewardship. NEW in @ICHEJournal by @JonChoIDhttps://t.co/IMNaVms8hA pic.twitter.com/54O5Mfsqof
— Antibiotic Steward (@ABsteward) December 19, 2018
Last week we launched two reports looking at the role of the environment in the spread of antimicrobial resistance 🌍 You can read them on our website➡️ https://t.co/7WMRJXV8Kq
— AMR at Wellcome (@Wellcome_AMR) December 17, 2018
We asked a group of experts why is it important we are talking about AMR in the environment anyway? pic.twitter.com/6FnRoGrfQo
Complications VERY common after d/c on OPAT for Staph aureus: 33% experienced an adverse event during OPAT, and 64% readmitted at 90 days. Outpatient Parenteral Therapy for Complicated Staphylococcus aureus Infections. @TperlTrish https://t.co/YNci33lnKE
— Paul Sax (@PaulSaxMD) December 30, 2018
Ok here is a challenge... find a good #abxstewardship resource that’s NOT listed here. Good luck!!! I even have kid activity book links in there! 😃
— Tim Gauthier (@IDstewardship) December 11, 2018
📲 https://t.co/ngpWDX78Fo
Great tools from amazing people found here... accessible 🌏🌍🌎 24/7/365 pic.twitter.com/aDW3YISn8T
Despite the very regular use of disinfectant wipes in hospitals, there are few studies with a clinical outcome supporting them. Enter this study from @drmarkgarvey showing that switching to a one-step disinfectant wipe reduces MRSA acquisition https://t.co/dxdhISgWer #aricjournal
— Jon Otter (@jonotter) December 20, 2018
Four really really knowledgeable people give us a mini-review on one of the scariest bacteria out there: #Acinetobacter
— Tim Gauthier (@IDstewardship) December 21, 2018
📲 https://t.co/0JrAMQUNdJ via @ASMicrobiology with @davidantibiotic
Def. one to put in your e-library. pic.twitter.com/ZNMb4v1V7y
Researchers analyzing soil from Ireland have discovered that it contains a previously unknown strain of bacteria that is effective against superbugs that are resistant to #antibiotics, including #MRSA
— Microbes&Infection (@MicrobesInfect) December 27, 2018
They named the new strain Streptomyces sp. myrophoreahttps://t.co/IvLXWZGWI9 pic.twitter.com/leU8RSAXTs
Plazomicin, a Next‐Generation Aminoglycoside. A NEW review article in @PharmacoJournal by Dr. Chahine et al. https://t.co/pBBSlJT5Uo pic.twitter.com/VvlJ3y8skR
— Antibiotic Steward (@ABsteward) December 4, 2018
Day #12 On-Service ID Learning Unit: Can you stop PCP prophylaxis with viral suppression and CD4 < 200? In this cohort study, for pts with CD4 100-200 on ART, the incidence of PCP was zero after stopping prophylaxis. (Which is what I do.) https://t.co/Z1Tlgin92W
— Paul Sax (@PaulSaxMD) December 8, 2018
A NEW Monte Carlo simulations Study in @BSACandJAC
— Antibiotic Steward (@ABsteward) December 7, 2018
Standard linezolid dosing in obese pneumonia patients with MRSA leads to unacceptably low PTA for patients <65 years old. https://t.co/SrUU01UMkI pic.twitter.com/eae1OzBzpn
Holiday ID Learning Unit #2: Clindamycin not recommended for endocarditis--commonly cited reason is "static" vs "cidal", but commonly cited case report of Rx failure may have been due to inducible resistance, and have nothing to do with this distinction. https://t.co/Z09PlzdPpT
— Paul Sax (@PaulSaxMD) December 23, 2018
A NEW🔥🔥large nationwide retrospective cohort study in VAMCs Just published in CMI @ESCMID by @CGentPharm
— Antibiotic Steward (@ABsteward) December 22, 2018
Fidaxomicin or oral vancomycin for severe CDI resulted in similar treatment outcomes.
FID Vs VAN ID debate continued! @TimbrookTT / @julie_justohttps://t.co/RP5BMCpAPx pic.twitter.com/UGgwZPmmCT
Watch our #research findings simplified to #animation : #socialscience study on implementation of #antimicrobialstewardship across 🇬🇧🇮🇳🇧🇫🇳🇴🇫🇷- #patientpublicengagement @ESRC @ARC_at_Imperial paper in press @PLOSONE https://t.co/GLQBvmC1dA pic.twitter.com/ASvQbCP9v0
— Esmita Charani (@e_charani) December 31, 2018
Raise your hand if you love your ED pharmacist or wish you had one! Catch this Wednesday session at #ASHP18 by @jlkoehl @EMpharmgirl
— SIDP (@SIDPharm) December 4, 2018
and @SIDPharm
member @ErinMcCreary on their critical role in antimicrobial stewardship. @accpemedprn @ASHP_EMPharm https://t.co/cBcZtqdOZJ pic.twitter.com/zhViynvHGb
It is time to define antimicrobial never events. A NEW article @ICHEJournal by @IDPharmacometrx/@IDPharmProf@n_mercuro. No free access 😞https://t.co/GevSbtsPxo pic.twitter.com/QrLx00uKSC
— Antibiotic Steward (@ABsteward) December 5, 2018
Great editorial by Nick Daneman on Shortening Antibiotic Treatment Durations for Bacteremia https://t.co/mAAwhdE5U1
— David Paterson (@davidantibiotic) December 14, 2018
NEW🔥 Systematic Review and Meta-analysis In @JAMA_current @JAMAInternalMed
— Antibiotic Steward (@ABsteward) December 21, 2018
Association of Corticosteroid Treatment With Outcomes in Adult Patients With Sepsishttps://t.co/bkyV9sU1IM pic.twitter.com/KJz2g7QHsk
Day #11 On-Service ID Learning Unit: Multiplex PCR for diagnosis of CNS infections may yield false + (as in this case report) and false - (esp HSV and cryptococcus) results. Tests increasingly used; larger validation studies warranted! (h/t @iddocjen) https://t.co/A9HWULtqMa
— Paul Sax (@PaulSaxMD) December 7, 2018
🆕 from @PublicHealthON: #Antimicrobialstewardship in long‐term care settings: meta‐analysis shows stewardship approaches in LTC associated with 14% reduction in antibiotic usehttps://t.co/yIFehwR7vL @AmerGeriatrics pic.twitter.com/uaCXdoeNNJ
— Brad Langford (@BRxAD) December 6, 2018
Check out our op-ed in the @LSJNews on why antibiotic stewardship is crucial now.https://t.co/wZukJElKzb
— Payal Patel (@Payal_Patel) December 7, 2018
Thanks to @uspirg and @matthewwell for writing this with me pic.twitter.com/W80p8wm9hb
#STUDY in Clinical Infectious Diseases: People vaccinated against #Flu 3 years in a row are at HIGHER risk of catching the fluhttps://t.co/1854vSEHdZ#LearnTheRisk #VaccineSafety #VaccineInjury #vaccines pic.twitter.com/K3Uj9qDQ0n
— LotusOak (@ViraBurnayeva) December 10, 2018
Omadacycline: A New Tetracycline Antibiotic. A NEW review article by Dr. Chahine in Annals of Pharmacotherapy. May be the first article with new credential #BCIDP @BPSweb 🧐https://t.co/irWPXmZJz4 pic.twitter.com/htXL9XsKAw
— Antibiotic Steward (@ABsteward) December 7, 2018
Antimicrobial chemical tied to #AntibioticResistance genes in dust - New study from @ASMicrobiology's @mSystemsJ https://t.co/MIUXwhOcCW @NorthwesternU
— ASM Newsroom (@ASMnewsroom) December 11, 2018
Interested in providing expert advice to government on healthcare-associated infection, antimicrobial resistance, antimicrobial and diagnostic stewardship? Apply for #aprhai membership Lay & experts -information packs are live on https://t.co/oALA9V9BMR.https://t.co/2IW17v2jhe
— Susan Hopkins (@SMHopkins) December 12, 2018
Holiday On-Service ID Learning Unit #3: Double beta lactam therapy (ampicillin + ceftriaxone) now frequently used in treatment of enterococcal endocarditis, and endorsed by guidelines. Can it be used in non-faecalis cases? https://t.co/38KLmOAtV5 pic.twitter.com/AscAASM5Mp
— Paul Sax (@PaulSaxMD) December 24, 2018
Blumenthal et al. published a great review on antibiotic allergy in @TheLancet - great overview for anyone embarking on penicillin allergy assessment and skin testing programs. https://t.co/UjYfwGKuF4 #antimicrobialstewardship #penicillinallergy
— PCN Allergy Assessment & Skin Testing (PAAST) (@PCN_Allergy) December 15, 2018
An American health care worker being being monitored at a Nebraska health care facility after possible exposure to the Ebola virus "is not ill and is not contagious," says an infectious diseases specialist with Nebraska Medicine. https://t.co/lwfIS0REQP
— NPR (@NPR) December 31, 2018
Created by Cameron Forbes. Last updated November 10, 2019 at 15:41 EST.